Latest stories

  • in

    Prophylactic monthly Garadacimab safe and effective against hereditary angioedema attacks

    A new trial found that prophylactic subcutaneous administration of garadacimab every month in adults and adolescents was safe and has significantly decreased the attacks of hereditary angioedema compared to placebo. The trial results were published in the journal The Lancet.  Dysregulation of the kallikrein–kinin system leads to a rare and potentially life-threatening genetic disease called […] More